Is it safe and what are the real risks beyond loose skin and “Ozempic face” – the gaunt ageing effect of drastic weight loss?

BAGSVAERD, Denmark I 19, 2024 I Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human ...

Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

I hope that by talking about this, it can maybe be a lesson to some people that it’s not worth it.” The post Model Shares ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Across all studies and doses, females lost up to 24.6% of body weight from baseline whereas men lost a maximum of 18.1% of ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study.

There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects.

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.